Jazz Pharmaceuticals Balance Sheet
JAZZ / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Jazz Pharmaceuticals had $11.7B in total assets and $4.3B in shareholders' equity as of FY2025. Total debt was $5.4B against $1.4B in cash, resulting in $4.0B net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.4B | $2.4B | $1.5B | $881.5M | $591.4M | $1.1B | $637.3M | $309.6M | $386.0M | $684.0M | $988.8M | $387.2M | $636.5M | $387.2M | $82.1M |
| Accounts Receivable | $830.7M | $716.8M | $705.8M | $651.5M | $563.4M | $396.5M | $356.0M | $263.8M | $224.1M | $234.2M | $209.7M | $186.4M | $124.8M | $75.5M | $34.4M |
| Inventory | $417.0M | $480.4M | $597.0M | $714.1M | $1.1B | $95.4M | $78.6M | $53.0M | $43.2M | $34.1M | $19.5M | $30.0M | $28.7M | $26.5M | $3.9M |
| Current Assets | $4.2B | $4.6B | $3.4B | $2.6B | $2.6B | $2.8B | $1.6B | $1.2B | $968.3M | $748.1M | $1.3B | $1.0B | $864.6M | $551.6M | $199.1M |
| PP&E (Net) | $199.9M | $173.4M | $169.6M | $228.1M | $256.8M | $127.9M | $105.0M | $200.4M | $170.1M | $107.5M | $85.6M | $58.4M | $14.2M | $7.3M | $1.6M |
| Goodwill | $1.8B | $1.7B | $1.8B | $1.7B | $1.8B | $958.3M | $920.0M | $927.6M | $947.5M | $893.8M | $657.1M | $702.7M | $450.5M | $442.6M | $38.2M |
| Total Assets | $11.7B | $12.0B | $11.4B | $10.8B | $12.3B | $6.5B | $5.5B | $5.2B | $5.1B | $4.8B | $3.3B | $3.3B | $2.2B | $2.0B | $253.6M |
| Current Liabilities | $2.2B | $1.0B | $1.5B | $933.2M | $809.3M | $653.7M | $364.5M | $345.5M | $293.9M | $257.4M | $226.6M | $216.8M | $204.0M | $191.5M | $52.9M |
| Total Debt | $5.4B | $6.1B | $5.7B | $5.7B | $6.0B | $2.1B | $1.6B | $1.6B | $1.6B | $2.0B | $1.2B | $1.3B | $550.0M | $427.1M | $0 |
| Shareholders' Equity | $4.3B | $4.1B | $3.7B | $3.1B | $4.0B | $3.7B | $2.7B | $2.7B | $2.7B | $1.4B | $1.6B | $1.4B | $1.3B | $1.1B | $192.8M |